Pfizer is looking for US approval of the booster dose of its two-shot COVID-19 vaccine. The drugmaker stated Wednesday that it has started out the application approach for a third dose of its vaccine for folks ages 16 and more mature. The corporate claimed it will complete the applying Along http://www.dmes.ylc.edu.tw/school/netlink/hits.php?id=20&url=https://getlisting.org/